Related Experiment Videos
Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes
David R Lynch1, Rodney P Guttmann
1Department of Neurology, University of Pennsylvania and The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-4318, USA. lynch@pharm.med.upenn.edu
The Journal of Pharmacology and Experimental Therapeutics
|February 28, 2002
Summary
Understanding N-methyl-D-aspartate (NMDA) receptor subtypes is crucial for treating excitotoxicity, a cell death pathway in neurological diseases. Research into NMDA receptor heterogeneity offers new therapeutic targets for better clinical treatments.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Excitotoxicity is implicated in various neuropathological conditions.
- The N-methyl-D-aspartate (NMDA) receptor is a key focus in excitotoxic research.
- Early NMDA receptor antagonism showed neuroprotection but had clinical limitations.
Purpose of the Study:
- To explore the relationship between NMDA receptor subtypes and excitotoxicity.
- To discuss models for studying NMDA receptor-mediated cell death.
- To highlight potential therapeutic targets based on NMDA receptor heterogeneity.
Main Methods:
- Review of molecular biological approaches to understand NMDA receptor heterogeneity.
- Analysis of various model systems for studying NMDA receptor-mediated cell death.
- Discussion of current understanding of NMDA receptor subtypes and excitotoxicity.
Main Results:
- Discovery of the basis of NMDA receptor heterogeneity.
- Identification of numerous potential therapeutic targets.
- Development of model systems for studying NMDA receptor-mediated cell death.
Conclusions:
- Understanding NMDA receptor subtypes is critical for developing effective treatments for excitotoxicity.
- NMDA receptor heterogeneity presents opportunities for targeted pharmacological interventions.
- Further research into NMDA receptor subtypes can advance clinical treatments for neurological diseases.